Trial · NCT04559529
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Hippocampal Activity (Arterial Spin Labeling [ASL] Study) After Levetiracetam (LEV) | Healthy Control Participants: Levetiracetam (LEV), Then Placebo | 28.3 | 95% Confidence Interval 25.2 to 31.3 | ml/100g/min | |
| Hippocampal Activity (Arterial Spin Labeling [ASL] Study) After Levetiracetam (LEV) | Healthy Control Participants: Placebo, Then Levetiracetam (LEV) | 27.1 | 95% Confidence Interval 24.9 to 29.4 | ml/100g/min | |
| Hippocampal Activity (Arterial Spin Labeling [ASL] Study) After Levetiracetam (LEV) | Patients With Schizophrenia: Levetiracetam (LEV), Then Placebo | 28.0 | 95% Confidence Interval 24.7 to 31.3 | ml/100g/min | |
| Hippocampal Activity (Arterial Spin Labeling [ASL] Study) After Levetiracetam (LEV) | Patients With Schizophrenia: Placebo, Then Levetiracetam (LEV) | 28.5 | 95% Confidence Interval 25.5 to 31.5 | ml/100g/min | |
| Hippocampal Activity (Arterial Spin Labeling [ASL] Study) After Placebo | Healthy Control Participants: Levetiracetam (LEV), Then Placebo | 28.1 | 95% Confidence Interval 25.6 to 30.5 | ml/100g/min | |
| Hippocampal Activity (Arterial Spin Labeling [ASL] Study) After Placebo | Healthy Control Participants: Placebo, Then Levetiracetam (LEV) | 28.3 | 95% Confidence Interval 25.2 to 31.4 | ml/100g/min | |
| Hippocampal Activity (Arterial Spin Labeling [ASL] Study) After Placebo | Patients With Schizophrenia: Levetiracetam (LEV), Then Placebo | 28.1 | 95% Confidence Interval 25.5 to 30.7 | ml/100g/min | |
| Hippocampal Activity (Arterial Spin Labeling [ASL] Study) After Placebo | Patients With Schizophrenia: Placebo, Then Levetiracetam (LEV) | 28.7 | 95% Confidence Interval 25.5 to 32.0 | ml/100g/min | |
| Hippocampal Recruitment (Blood-Oxygen-Level-Dependent [BOLD] Study) After Levetiracetam (LEV) | Healthy Control Participants: Levetiracetam (LEV), Then Placebo | -0.0342 | 95% Confidence Interval -0.2172 to 0.1489 | BOLD percent signal change | |
| Hippocampal Recruitment (Blood-Oxygen-Level-Dependent [BOLD] Study) After Levetiracetam (LEV) | Healthy Control Participants: Placebo, Then Levetiracetam (LEV) | 0.1216 | 95% Confidence Interval -0.0382 to 0.2813 | BOLD percent signal change | |
| Hippocampal Recruitment (Blood-Oxygen-Level-Dependent [BOLD] Study) After Levetiracetam (LEV) | Patients With Schizophrenia: Levetiracetam (LEV), Then Placebo | 0.2915 | 95% Confidence Interval 0.1084 to 0.4745 | BOLD percent signal change | |
| Hippocampal Recruitment (Blood-Oxygen-Level-Dependent [BOLD] Study) After Levetiracetam (LEV) | Patients With Schizophrenia: Placebo, Then Levetiracetam (LEV) | 0.2381 | 95% Confidence Interval -0.0078 to 0.4840 | BOLD percent signal change | |
| Hippocampal Recruitment (Blood-Oxygen-Level-Dependent [BOLD] Study) After Placebo | Healthy Control Participants: Levetiracetam (LEV), Then Placebo | 0.1908 | 95% Confidence Interval -0.0158 to 0.3975 | BOLD percent signal change | |
| Hippocampal Recruitment (Blood-Oxygen-Level-Dependent [BOLD] Study) After Placebo | Healthy Control Participants: Placebo, Then Levetiracetam (LEV) | 0.0507 | 95% Confidence Interval -0.1081 to 0.2094 | BOLD percent signal change | |
| Hippocampal Recruitment (Blood-Oxygen-Level-Dependent [BOLD] Study) After Placebo | Patients With Schizophrenia: Levetiracetam (LEV), Then Placebo | 0.1769 | 95% Confidence Interval -0.0607 to 0.4146 | BOLD percent signal change | |
| Hippocampal Recruitment (Blood-Oxygen-Level-Dependent [BOLD] Study) After Placebo | Patients With Schizophrenia: Placebo, Then Levetiracetam (LEV) | 0.0703 | 95% Confidence Interval -0.1121 to 0.2526 | BOLD percent signal change |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04559529/results